中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 10
Oct.  2014

Anxiety in mice with acute hepatic encephalopathy induced by thioacetamide

DOI: 10.3969/j.issn.1001-5256.2014.10.024
  • Received Date: 2014-02-15
  • Published Date: 2014-10-20
  • Objective To evaluate the mental disorders in mice with thioacetamide ( TAA) -induced acute hepatic encephalopathy ( AHE) .Methods Thirty male Kunming mice were equally and randomly divided into two groups ( treatment group and control group) . Mice in the treatment group received an intraperitoneal injection of TAA ( 200 mg·kg-1·d-1for 3 days, up to 600 mg·kg-1) , as compared with the same volume of physiological saline in the control group. Neurological function score, light /dark box, open field, and elevated plus-maze test were used to determine behavioral parameters at 24 h after the model was established. Serum ammonia, aspartate amino transferase ( AST) , alanine aminotransferase ( ALT) , and total bilirubin ( TBil) were measured at 24 h post determination of behavioral parameters. Comparison between two groups was made by independent-samples t test. Results In the light /dark box test, the treatment group had significantly reduced residence time in the light box and number of shuttles between two boxes ( t =-4. 006, P < 0. 01; t =-2. 656, P < 0. 05) ; in the open field test, the treatment group had significantly reduced central distance, central time, and number of vertical movements ( t =-3. 639, P < 0. 05;t =-2. 294, P < 0. 05; t =-2. 282, P < 0. 05) , as well as increased grooming time ( t = 5. 992, P < 0. 01) ; meanwhile, the number of open-arm entries and residence time in the open arm for the treatment group were also reduced in the elevated plus-maze test, as compared with the control group ( t =-3. 584, P < 0. 05; t =-3. 992, P < 0. 05) . However, the total distance in the open field test showed no significant difference between the two groups ( t =-0. 96, P > 0. 05) . Moreover, compared with the control group, the treatment group had significantly higher levels of serum ammonia ( t =-3. 168, P < 0. 05) , ALT ( t = 4. 316, P < 0. 05) , AST ( t =-2. 581, P < 0. 05) , and TBil ( t =-9. 127, P < 0. 01) . Conclusion Mice with AHE induced by an intraperitoneal injection of low-dose TAA have anxiety-related behaviors; the anxiety-related behaviors are not associated with reduced locomotor activities.

     

  • [1]LES I, DOVAL E, FLAVIM, et al.Quality of life in cirrhosis is related to potentially treatable factors[J].Eur J Gastroenterol Hepatol, 2010, 22 (2) :221-227.
    [2]NARDELLI S, PENTASSUGLIO I, PASQUALE C, et al.Depression, anxiety and alexithymia symptoms are major determinants of health related quality of life (HRQoL) in cirrhotic patients[J].Metab Brain Dis, 2013, 28 (2) :239-243.
    [3]ROEST AM, THOMBS BD, GRACE SL, et al.Somatic/affective symptoms, but not cognitive/affective symptoms, of depression after acute coronary syndrome are associated with 12-month all-cause mortality[J].J Affect Disord, 2011, 131 (1-3) :158-163.
    [4]KAUHANEN J, KAPLAN G, COHEN R, et al.Alexithymia and risk of death in middle-aged men[J].J Psychosom Res, 1996, 41 (6) :541-549.
    [5]JIANG H, XIE Q.Advances in the diagnosis and treatment of hepatic encephalopathy[J].J Clin Hepatol, 2011, 27 (10) :1027-1031. (in Chinese) 姜浩, 谢青.肝性脑病临床诊治的进展[J].临床肝胆病杂志, 2011, 27 (10) :1027-1031.
    [6]FERENCI P, LOCKWOOD A, MULLEN K, et al.Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification:final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998[J].Hepatology, 2002, 35 (3) :716-721.
    [7]BUTTERWORTH RF, NORENBERG MD, FELIPO V, et al.Experimental models of hepatic encephalopathy:ISHEN guidelines[J].Liver Int, 2009, 29 (6) :783-788.
    [8]MIRANDA AS, RODRIGUES DH, VIEIRA LB, et al.A thioacetamide-induced hepatic encephalopathy model in C57BL/6 mice:a behavioral and neurochemical study[J].Arq Neuropsiquiatr, 2010, 68 (4) :597-602.
    [9]AVRAHAM Y, GRIGORIADIS N, POUTAHIDIS T, et al.Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice[J].Br J Pharmacol, 2011, 162 (7) :1650-1658.
    [10]LI X, RISBROUGH VB, CATES-GATTO C, et al.Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice[J].Neuropharmacology, 2013, 70 (2) :156-167.
    [11]CAROLA V, D'OLIMPIO F, BRUNAMONTI E, et al.Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice[J].Behav Brain Res, 2002, 134 (1-2) :49-57.
    [12]LAU AA, CRAWLEY AC, HOPWOOD JJ, et al.Open field locomotor activity and anxiety-related behaviors in mucopolysaccharidosis type IIIA mice[J].Behav Brain Res, 2008, 191 (1) :130-136.
    [13]NEWMAN MG, LLERA SJ, ERICKSON TM, et al.Worry and generalized anxiety disorder:a review and theoretical synthesis of evidence on nature, etiology, mechanisms, and treatment[J].Annu Revi Clin Psychol, 2013, 9:275-297.
    [14]RUSCIO A, CHIU W, ROY-BYRNE P, et al.Broadening the definition of generalized anxiety disorder:effects on prevalence and associations with other disorders in the National Comorbidity Survey Replication[J].J Anxiety Disord, 2007, 21 (5) :662-676.
    [15]GRANT B, HASIN D, STINSON F, et al.Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA:results from the National Epidemiologic Survey on Alcohol and Related Conditions[J].Psychol Med, 2005, 35 (12) :1747-1759.
    [16]SCHIENLE A, HETTEMA JM, CCEDA R, et al.Neurobiology and genetics of generalized anxiety disorder[J].Psychiatr Ann, 2011, 41 (2) :113-123.
    [17]YASSA M, HAZLETT R, STARK C, et al.Functional MRI of the amygdala and bed nucleus of the stria terminalis during conditions of uncertainty in generalized anxiety disorder[J].J Psychiatr Res, 2012, 46 (8) :1045-1052.
    [18]HERDEN C, BEINEKE A, HETZEL U, et al.Unusual manifestation of hepatic encephalopathy in two Irish wolfhound siblings[J].Vet Rec, 2003, 153 (22) :682-686.
    [19]CAULI O, LLANSOLA M, ERCEG S, et al.Hypolocomotion in rats with chronic liver failure is due to increased glutamate and activation of metabotropic glutamate receptors in substantia nigra[J].J Hepatol, 2006, 45 (5) :654-661.
    [20]SERGEEVA OA, SCHULZ D, DOREULEE N, et al.Deficits in cortico-striatal synaptic plasticity and behavioral habituation in rats with portacaval anastomosis[J].Neuroscience, 2005, 134 (4) :1091-1098.
    [21]LEKE R, BAK L, IVERSEN P, et al.Synthesis of neurotransmitter GABA via the neuronal tricarboxylic acid cycle is elevated in rats with liver cirrhosis consistent with a high GABAergic tone in chronic hepatic encephalopathy[J].J Neurochem, 2011, 117 (5) :824-832.
    [22]WESIERSKA M, KLINOWSKA HD, ADAMSKA I, et al.Cognitive flexibility but not cognitive coordination is affected in rats with toxic liver failure[J].Behav Brain Res, 2006, 171 (1) :70-77.
  • Relative Articles

    [1]LI Hui, WANG YongGang, SU HaiBin. Application of blood lactate level in evaluating the prognosis of liver failure patients[J]. Journal of Clinical Hepatology, 2020, 36(11): 2609-2612. doi: 10.3969/j.issn.1001-5256.2020.11.048
    [2]Yao YunHai, Gan JianHe, Zhao WeiFeng. Effect of plasma exchange combined with continuous renal replacement therapy on the prognosis of patients with HBV-related acute-on-chronic liver failure and acute kidney injury[J]. Journal of Clinical Hepatology, 2019, 35(5): 1065-1069. doi: 10.3969/j.issn.1001-5256.2019.05.026
    [3]Liu YeYing, Wang Ting, Dou AiHua, Zheng SuJun, Xu Bin, Liu Mei. Current status and perspectives of prognostic markers for liver failure[J]. Journal of Clinical Hepatology, 2019, 35(5): 1135-1139. doi: 10.3969/j.issn.1001-5256.2019.05.046
    [4]Zhang DongJing, Zhou Bin, Hou JinLin. Research progress in prognostic models of acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2018, 34(6): 1351-1356. doi: 10.3969/j.issn.1001-5256.2018.06.047
    [5]Han PuQing, Sun Yan. Prognostic models for liver failure and their role in pregnant women with liver failure[J]. Journal of Clinical Hepatology, 2018, 34(3): 635-640. doi: 10.3969/j.issn.1001-5256.2018.03.044
    [6]Zhang Li, Chen Wen, Sheng YunJian, Deng CunLiang. Value of Model for End-Stage Liver Disease score combined with neutrophil-lymphocyte ratio in predicting the short-term prognosis of patients with HBV-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2018, 34(3): 553-557. doi: 10.3969/j.issn.1001-5256.2018.03.021
    [7]Li Ying, Zhan Jing, Wang ZhongFeng. Prognostic factors for patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2017, 33(3): 497-501. doi: 10.3969/j.issn.1001-5256.2017.03.020
    [8]Lin Feng. Research advances in clinical diagnosis,prognostic evaluation,and treatment of liver failure[J]. Journal of Clinical Hepatology, 2016, 32(9): 1678-1683. doi: 10.3969/j.issn.1001-5256.2016.09.009
    [9]Zhang Jing, Zhou XinMin. Disease assessment and prognosis of liver failure[J]. Journal of Clinical Hepatology, 2016, 32(9): 1673-1677. doi: 10.3969/j.issn.1001-5256.2016.09.008
    [10]Shi XinXing, Zhang YanQiong, Zhu Peng, Yan GuoHua, Zhang ZhangJiang, Wang YuMing. Prognostic risk factors in patients with hepatitis B virus- related acute- on- chronic liver failure[J]. Journal of Clinical Hepatology, 2016, 32(4): 700-705. doi: 10.3969/j.issn.1001-5256.2016.04.018
    [11]Tang ShanHong, Zeng WeiZheng, Jiang MingDe, Fan QuanShui. Research progress in prediction of clinical outcome in patients with liver failure[J]. Journal of Clinical Hepatology, 2015, 31(1): 135-138. doi: 10.3969/j.issn.1001-5256.2015.01.031
    [12]Han Tao, Zhang YuLing. Predictive and prognostic evaluation of hepatitis B virus-induced liver failure[J]. Journal of Clinical Hepatology, 2015, 31(4): 505-509. doi: 10.3969/j.issn.1001-5256.2015.04.007
    [13]Zhang Xin, Gan QiaoRong, Wang Ning, Pan Chen. Analysis of influencing factors for short-term outcome in patients with hepatitis B virus-related acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2015, 31(5): 706-710. doi: 10.3969/j.issn.1001-5256.2015.05.018
    [14]Zhang YuLing, Han Tao, Zhang Min, Zhang Qian. Research progress in prognostic markers of acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2014, 30(10): 1078-1081. doi: 10.3969/j.issn.1001-5256.2014.10.026
    [15]Liu JieYu, Feng YiChao. Analysis of prognostic models for liver failure  [J]. Journal of Clinical Hepatology, 2014, 30(10): 1082-1086. doi: 10.3969/j.issn.1001-5256.2014.10.027
    [16]Wu XiaoQing, Wan Hong. Causes of liver failure and impact analysis of prognostic risk factors[J]. Journal of Clinical Hepatology, 2013, 29(4): 294-296+304.
    [17]Ye PeiYan, Yang ZongGuo, Chen XiaoRong, Lu YunFei. Risk factors associated with prognosis of progressive stages of acute-on-chronic hepatitis B liver failure[J]. Journal of Clinical Hepatology, 2013, 29(4): 270-275.
    [18]Yang Bo, Wu YuanKai, Chen ZhongCheng, Gao ZhiLiang, Chong YuTian, Xie ShiBin. The dynamic changes of AST, ALT, TBil and PT and their relationship with prognosis of acute-on-chronic hepatitis B liver failure[J]. Journal of Clinical Hepatology, 2012, 28(3): 205-208.
    [19]Peng JianPing, Sun KeWei, Wu YuNan. Impact of early virological response to antiviral treatment on the outcomes of hepatitis B-associated liver failure [J]. Journal of Clinical Hepatology, 2012, 28(10): 752-755.
    [20]Zhang DongQing, Chen Li, Gan QiaoRong, Zhou Rui, Huang JianRong, Pan Chen. Prognostic factors for hepatitis B acute-on-chronic liver failure[J]. Journal of Clinical Hepatology, 2012, 28(10): 740-743.
  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-040510152025
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 3.2 %FULLTEXT: 3.2 %META: 93.4 %META: 93.4 %PDF: 3.4 %PDF: 3.4 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 5.7 %其他: 5.7 %其他: 0.4 %其他: 0.4 %Mexico: 0.4 %Mexico: 0.4 %Russian Federation: 0.2 %Russian Federation: 0.2 %[]: 0.6 %[]: 0.6 %上海: 1.9 %上海: 1.9 %北京: 5.3 %北京: 5.3 %南宁: 0.2 %南宁: 0.2 %台北: 0.2 %台北: 0.2 %吉林: 0.9 %吉林: 0.9 %哥伦布: 0.6 %哥伦布: 0.6 %圣彼得堡: 0.2 %圣彼得堡: 0.2 %宜春: 0.9 %宜春: 0.9 %张家口: 2.8 %张家口: 2.8 %昆明: 0.2 %昆明: 0.2 %杭州: 0.4 %杭州: 0.4 %武汉: 0.9 %武汉: 0.9 %济南: 0.2 %济南: 0.2 %深圳: 0.2 %深圳: 0.2 %石家庄: 0.4 %石家庄: 0.4 %芒廷维尤: 37.2 %芒廷维尤: 37.2 %芝加哥: 0.4 %芝加哥: 0.4 %莫斯科: 2.3 %莫斯科: 2.3 %西宁: 36.2 %西宁: 36.2 %贵港: 0.2 %贵港: 0.2 %长春: 0.6 %长春: 0.6 %长治: 0.2 %长治: 0.2 %其他其他MexicoRussian Federation[]上海北京南宁台北吉林哥伦布圣彼得堡宜春张家口昆明杭州武汉济南深圳石家庄芒廷维尤芝加哥莫斯科西宁贵港长春长治

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (3045) PDF downloads(547) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return